The Food and Drug Administration (FDA) wasn't resting on its laurels in 2017: The agency under new commissioner Scott Gottlieb approved 46 new medicines — i.e., completely new therapies, not
just additional indications on already - approved drugs — the highest number of approvals in more than two decades.